Global Drug Safety Solutions and Pharmacovigilance Market Key Opinion Leaders (KOL’s): Doctors, Healthcare Professionals, Researchers, Distributors, and Industrialists | DBMR

Drug Safety Solutions and Pharmacovigilance Market is projected to register a substantial CAGR of 7.4% in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

According to the statistics published in The Global Cancer Observatory, Globocan 2018, it is estimated that the total incident population of Non-Hodgkin lymphoma and breast cancer worldwide were 509,590 and 2,088,849 respectively. This growing incidence of cancer globally and increase in deal between the companies are acts as market drivers.

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-safety-solutions-and-pharmacovigilance-market

List Of Table:

TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS

TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE

TABLE 3 GLOBAL DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 4 GLOBAL SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 5 GLOBAL DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 6 GLOBAL ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 GLOBAL ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 8 GLOBAL DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 GLOBAL DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

Continued…

Competitive Analysis: Global Drug Safety Solutions and Pharmacovigilance Market​​​​​​​

Some of the major players operating in global drug safety solutions and pharmacovigilance market are Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Covance Inc., Accenture, PRA Health Sciences, Inc., Ergomed, IQVIA, Genpact, Cognizant, Parexel International Corporation, ArisGlobal, ICON plc, Oracle, Syneos Health among others.

 Recent Developments:

• In October 2019, Laboratory Corporation of America Health EC and The New Jersey announced the collaboration and development of a database and information exchange platform. This platform will be useful through LabCorp’s Care Intelligence application. This collaboration will lead to LabCorp improved lives and improved health. This will give more patient satisfaction and recognition.
• In October 2019, Parexel International Corporation announced that they have entered into a strategic partnership with Datavant, Inc. to allow the connection of real-world data including all clinical trials which is conducted by Parexel. This partnership will expand and extend companies entire portfolio which have ability to link data available to more customers.
• In September 2019, Accenture has announced its collaboration with Bayer. The purpose of collaboration will be Streamline Drug Development Processes through INTIENT Clinical Platform. With this collaboration Accenture will lead to develop high quality of data, and will increase its product portfolio.

For More Insights Get FREE COVID-19 Impact @ https://www.databridgemarketresearch.com/covid-19-impact/global-drug-safety-solutions-and-pharmacovigilance-market

Drivers: Drug Safety Solutions and Pharmacovigilance Market

• Increase in R & D expenditure by pharmaceutical and biopharmaceutical companies
• Increase in the number of adverse drug reactions (ADRS)

Restraint:

• High cost of drug safety solutions & pharmacovigilance

Opportunities:

• Automation in drug safety solutions & pharmacovigilance
• Research collaborate ions and partnerships
• Strategic initiatives by market players

Challenge:

• The misreporting and miscoding of adverse events

About Data Bridge Market Research: 

Data Bridge Market Research set forward itself as an offbeat and neoteric Market examination and advising firm with unrivaled level of solidarity and facilitated approaches. We have made plans to reveal the best market openings and empower powerful information for your business to thrive by keeping watch. Data Bridge attempts to offer reasonable responses for the confounding business troubles and starts a simple unique communication. Data associate is a consequence of sheer understanding and experience which was nitty gritty and illustrated in the year 2015 in Pune. 

Contact Us:- 

Data Bridge Market research 

US: +1 888 387 2818 

UK: +44 208 089 1725 

Hong Kong: +852 8192 7475 

Email:- corporatesales@databridgemarketresearch.com